MARK CLARK: Open Payments
NPI 1285631887 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,919 in 88 payments from 32 companies in 2025. Trend: 2023 $2,317 · 2024 $1,759 · 2025 $2,919
Food & beverage: $1,874Consulting: $932Education: $113
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 1 | $932 |
| Daiichi Sankyo Inc. | 4 | $164 |
| Janssen Biotech, Inc. | 9 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $140 |
| Merck Sharp & Dohme LLC | 5 | $131 |
| PFIZER INC. | 6 | $125 |
| ABBVIE INC. | 5 | $113 |
| E.R. Squibb & Sons, L.L.C. | 6 | $112 |
| Astellas Pharma US Inc | 3 | $102 |
| AstraZeneca Pharmaceuticals LP | 4 | $96 |
Products named: LIBTAYO, ENHERTU, Nubeqa, KEYTRUDA, TALVEY, REBLOZYL, IBRANCE, BRUKINSA.
Industry payments across GA — which companies pay providers there.
